Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some
Patients with nasopharyngeal cancer who received the Chinese Sinovac COVID-19 vaccine did better on immune checkpoint inhibitor therapy compared with unvaccinated patients, early data suggest.
Source: medscape.com